Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect

Abstract Background A reliable and effective method is required to deliver agent that can aid the in vivo imaging of retinal vessels. The aim of the present study was to evaluate retro-orbital (RO) injection of fluorescein-labeled isothiocyanate dextran (FITC-dextran) as a method of demonstrating re...

Full description

Bibliographic Details
Main Authors: Jizhu Li, Yuqing Wu, Bingqian Liu, Ying Huang, Qingxiu Wu, Haichun Li, Sainan Xiao, Ying Lin, Tao Li
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-021-01969-5
id doaj-08fd6e6b8e4040db985fca08c56598a6
record_format Article
spelling doaj-08fd6e6b8e4040db985fca08c56598a62021-05-11T14:52:55ZengBMCBMC Ophthalmology1471-24152021-05-012111910.1186/s12886-021-01969-5Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defectJizhu Li0Yuqing Wu1Bingqian Liu2Ying Huang3Qingxiu Wu4Haichun Li5Sainan Xiao6Ying Lin7Tao Li8State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityAbstract Background A reliable and effective method is required to deliver agent that can aid the in vivo imaging of retinal vessels. The aim of the present study was to evaluate retro-orbital (RO) injection of fluorescein-labeled isothiocyanate dextran (FITC-dextran) as a method of demonstrating retinal neovascularization (NV) and avascular areas in oxygen-induced retinopathy (OIR) mice. Methods Different concentrations of FITC-dextran were used to compare the efficacy of this agent in perfusing the retinal vessels. Hematoxylin–eosin (HE) staining was used to evaluate the safety of RO injection. The vitreous blood vessels and extent of NV were assessed in P17 OIR mice using FITC-dextran and compared with the corresponding measurements obtained following isolectin B4 staining or the combination of both methods. Results The fluorescence of small vessels and neovascular tufts could be observed clearly following RO injection of 0.05 ml of 25 mg/ml or 50 mg/ml FITC-dextran. No visible damage to tissues adjacent to the injection site was discovered. Vitreous blood flow was gradually reduced from P0 to P5 and eventually disappeared in P17 OIR mice, as demonstrated by FITC-dextran perfusion. The retinal NV areas assessed by isolectin B4 were larger than those assessed by FITC-dextran, but the retinal avascular areas were smaller. The combination of both methods could conduce to distinguish non-functional blood vessels. Conclusions RO injection of FITC-dextran combined with isolectin B4 is an effective, optimal method for assessing the NV area and avascular area.https://doi.org/10.1186/s12886-021-01969-5Retro‐orbital injectionIsolectin B4FITC-dextranNeovascularizationRetinaVitreous blood vessel
collection DOAJ
language English
format Article
sources DOAJ
author Jizhu Li
Yuqing Wu
Bingqian Liu
Ying Huang
Qingxiu Wu
Haichun Li
Sainan Xiao
Ying Lin
Tao Li
spellingShingle Jizhu Li
Yuqing Wu
Bingqian Liu
Ying Huang
Qingxiu Wu
Haichun Li
Sainan Xiao
Ying Lin
Tao Li
Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect
BMC Ophthalmology
Retro‐orbital injection
Isolectin B4
FITC-dextran
Neovascularization
Retina
Vitreous blood vessel
author_facet Jizhu Li
Yuqing Wu
Bingqian Liu
Ying Huang
Qingxiu Wu
Haichun Li
Sainan Xiao
Ying Lin
Tao Li
author_sort Jizhu Li
title Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect
title_short Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect
title_full Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect
title_fullStr Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect
title_full_unstemmed Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect
title_sort retro-orbital injection of fitc-dextran combined with isolectin b4 in assessing the retinal neovascularization defect
publisher BMC
series BMC Ophthalmology
issn 1471-2415
publishDate 2021-05-01
description Abstract Background A reliable and effective method is required to deliver agent that can aid the in vivo imaging of retinal vessels. The aim of the present study was to evaluate retro-orbital (RO) injection of fluorescein-labeled isothiocyanate dextran (FITC-dextran) as a method of demonstrating retinal neovascularization (NV) and avascular areas in oxygen-induced retinopathy (OIR) mice. Methods Different concentrations of FITC-dextran were used to compare the efficacy of this agent in perfusing the retinal vessels. Hematoxylin–eosin (HE) staining was used to evaluate the safety of RO injection. The vitreous blood vessels and extent of NV were assessed in P17 OIR mice using FITC-dextran and compared with the corresponding measurements obtained following isolectin B4 staining or the combination of both methods. Results The fluorescence of small vessels and neovascular tufts could be observed clearly following RO injection of 0.05 ml of 25 mg/ml or 50 mg/ml FITC-dextran. No visible damage to tissues adjacent to the injection site was discovered. Vitreous blood flow was gradually reduced from P0 to P5 and eventually disappeared in P17 OIR mice, as demonstrated by FITC-dextran perfusion. The retinal NV areas assessed by isolectin B4 were larger than those assessed by FITC-dextran, but the retinal avascular areas were smaller. The combination of both methods could conduce to distinguish non-functional blood vessels. Conclusions RO injection of FITC-dextran combined with isolectin B4 is an effective, optimal method for assessing the NV area and avascular area.
topic Retro‐orbital injection
Isolectin B4
FITC-dextran
Neovascularization
Retina
Vitreous blood vessel
url https://doi.org/10.1186/s12886-021-01969-5
work_keys_str_mv AT jizhuli retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect
AT yuqingwu retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect
AT bingqianliu retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect
AT yinghuang retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect
AT qingxiuwu retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect
AT haichunli retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect
AT sainanxiao retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect
AT yinglin retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect
AT taoli retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect
_version_ 1721443827507527680